COMMUNIQUÉS West-GlobeNewswire

American Academy of Dermatology PSA Highlights Dangers of Tanning
22/05/2018
Teenage girls encouraged to reduce their skin cancer risk by protecting themselves from harmful UV rays ROSEMONT, Ill., May 22, 2018 (GLOBE NEWSWIRE) -- As Memorial Day signals the unofficial start of summer, many teen [...]
CORRECTING and REPLACING – Protomer Technologies Takes Top Prize in 2018 Diabetes Innovation Challenge
22/05/2018
Revolutionary “smart” drug could prevent hypoglycemia in people with diabetes In a release issued under the same headline earlier today by T1D Exchange please note that in the third paragraph of the release the name of [...]
Fexapotide Triflutate Pivotal Phase 3 Study Results Presented and Discussed at American Urological Association Annual Meeting in San Francisco
22/05/2018
HASBROUCK HEIGHTS, N.J., May 22, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) is pleased to report on a successful symposium discussing Nymox’s lead product candidate Fexapotide Triflutate ( [...]
Florida Hospital Waterman offers new non-invasive treatment option for prostate cancer
22/05/2018
CHARLOTTE, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- Florida Hospital Waterman now offers HIFU, High Intensity Focused Ultrasound, for prostate cancer available for men with localized prostate cancer. HIFU is a non- [...]
ICC Labs Signs LOI to Export Cannabis to Germany for Medicinal Purposes
22/05/2018
VANCOUVER, British Columbia, May 22, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V: ICC ) (Frankfurt: 2Q9 ) is pleased to announce that it has signed a letter of intent with CanPharma GmbH [...]
Arch Biopartners Engages Nucro-Technics To Complete Toxicology Studies To Support Investigational New Drug Application For Metablok
22/05/2018
TORONTO, May 22, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners, Inc., (Arch or the Company) (TSX Venture:ARCH) (OTCQB:ACHFF) a portfolio-based biotechnology company, today announced it has engaged Nucro-Technics in [...]
Fort Worth Plastic Surgeon Jon Kurkjian, MD Earns Esteemed RealSelf 100 Award
22/05/2018
Dr. Jon Kurkjian was recognized as one of the most engaging, helpful, and respected aesthetic practitioners on RealSelf. FORT WORTH, Texas, May 22, 2018 (GLOBE NEWSWIRE) -- Jon Kurkjian, MD, a plastic surgeon in Fort [...]
Alberta’s Top Business Leaders Announced for 2018 CEO Rescue in the Rockies for STARS
22/05/2018
Prominent Alberta-based CEOs will be airlifted into the wilderness for annual fundraiser CALGARY, Alberta, May 22, 2018 (GLOBE NEWSWIRE) -- The Shock Trauma Air Rescue Service (STARS), a non-profit helicopter air [...]
Medecision Acquires Transformational Change Firm, Aveus
22/05/2018
Helps Medecision’s clients assess and accelerate population health strategies and outcomes DALLAS and MINNEAPOLIS, May 22, 2018 (GLOBE NEWSWIRE) -- Medecision , a leader in population health management solutions, [...]
Progyny Named to the 2018 CNBC Disruptor 50 List
22/05/2018
The fertility benefits management company placed #15 and for the second year in a row is among 50 companies that collectively have the potential to upend multibillion-dollar industries NEW YORK, May 22, 2018 (GLOBE [...]
CV Sciences, Inc. to Present at 8th Annual LD Micro Invitational on June 4-6, 2018 in Bel-Air, California
22/05/2018
LAS VEGAS, May 22, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. , (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent manufacturer and distributor of the leading brand of hemp extract products, PlusCBD [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants - FIT Biotech's own equity positive with draw down of fourth Tranche
22/05/2018
FIT Biotech Oy Company release May 22, 2018 at 3:30 pm EET FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants - FIT Biotech's own equity positive with draw down of fourth [...]
Ritter Pharmaceuticals to Present Two Posters at Digestive Disease Week 2018 Highlighting Treatment Data of RP-G28 for Lactose Intolerance
22/05/2018
LOS ANGELES, May 22, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the gut microbiome to treat [...]
Yield10 Bioscience Exercises Option with University of Missouri to Obtain Exclusive Worldwide License to Advanced Technologies for Oilseed Crops
22/05/2018
WOBURN, Mass., May 22, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today [...]
Zosano Appoints Steven A. Elms to Board of Directors
22/05/2018
FREMONT, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]
Progenics Announces JAMA Oncology Publication Highlighting Company’s Imaging Analysis Platform
22/05/2018
Data Support Prognostic Utility of aBSI as an Imaging Biomarker for Survival in Patients with Castration-Resistant Prostate Cancer NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX [...]
Oxford Immunotec Announces Launch of the Accutix™ Brand
22/05/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 22, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced the launch of the Accutix brand for [...]
BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board
22/05/2018
RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) today announced it has closed its previously announced $50 million registered direct offering of newly designated [...]
Novo Nordisk A/S - Share repurchase programme
22/05/2018
Bagsværd, Denmark, 22 May 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]

Pages